Please login to the form below

Not currently logged in
Email:
Password:

Delinia

This page shows the latest Delinia news and features for those working in and with pharma, biotech and healthcare.

Syncona launches another cell therapy company, Treg specialist Quell

Syncona launches another cell therapy company, Treg specialist Quell

Previous deals saw Celgene swoop on Delinia and its Treg therapies for autoimmune conditions, paying $300m upfront for the company, while Eli Lilly paid $150m for co-development rights to a ... Delinia’s DEL106 acts as an interleukin-2 (IL-2) mutein Fc

Latest news

  • Celgene pays $300m upfront for immunology start-up Delinia Celgene pays $300m upfront for immunology start-up Delinia

    Celgene has made another bolt-on acquisition, paying $300m upfront and $475m in milestones for Delinia and its immunology and inflammation programmes. ... The scale of the deal is eye-opening given that Delinia's lead candidate is still in preclinical

More from news
Approximately 1 fully matching, plus 1 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Hamell

Hamell is a full-service agency with a clear focus on delivering evidence-based, sustained behaviour change. So, whether you are looking...

Latest intelligence

What does the future hold for Light-chain Amyloidosis?
Recent advances in the understanding and treatment are reforming pharma’s approach to the management of this rare disease. With a new standard of care rapidly developing, what does the landscape...
Webinar:
Securing a future for telehealth with immersive market research insights...
Accelerating patient recruitment in clinical trials with the Clinical Enrolment Managers (CEMs)
How Innovative Trials' global Clinical Enrolment Managers (CEMs) give clinical trial sites the local touch...